The Janus kinases (Jaks)
- PMID: 15575979
- PMCID: PMC545791
- DOI: 10.1186/gb-2004-5-12-253
The Janus kinases (Jaks)
Abstract
The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases. Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2). Birds, fish and insects also have Jaks. Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains. Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family. Mutations of the Drosophila Jak (Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes. Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established. Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency (SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.
Figures


Similar articles
-
CXCL12 signaling is independent of Jak2 and Jak3.J Biol Chem. 2005 Apr 29;280(17):17408-14. doi: 10.1074/jbc.M414219200. Epub 2004 Dec 20. J Biol Chem. 2005. PMID: 15611059
-
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions.Front Endocrinol (Lausanne). 2017 Apr 18;8:71. doi: 10.3389/fendo.2017.00071. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28458652 Free PMC article. Review.
-
JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.Semin Cell Dev Biol. 2008 Aug;19(4):385-93. doi: 10.1016/j.semcdb.2008.07.002. Epub 2008 Jul 17. Semin Cell Dev Biol. 2008. PMID: 18682296 Review.
-
Cross-regulation of JAK and Src kinases.Growth Factors. 2006 Mar;24(1):89-95. doi: 10.1080/08977190500368031. Growth Factors. 2006. PMID: 16393697 Review.
-
JAK protein kinase inhibitors.Drug News Perspect. 2005 Jun;18(5):305-10. doi: 10.1358/dnp.2005.18.5.904198. Drug News Perspect. 2005. PMID: 16193102 Review.
Cited by
-
The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential.Ther Adv Musculoskelet Dis. 2013 Feb;5(1):3-11. doi: 10.1177/1759720X12470753. Ther Adv Musculoskelet Dis. 2013. PMID: 23515130 Free PMC article.
-
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol.J Biol Chem. 2015 Feb 20;290(8):4573-4589. doi: 10.1074/jbc.M114.595181. Epub 2014 Dec 31. J Biol Chem. 2015. PMID: 25552479 Free PMC article.
-
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches.Drug Des Devel Ther. 2024 Sep 20;18:4215-4240. doi: 10.2147/DDDT.S475005. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39319193 Free PMC article. Review.
-
The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.Cell Commun Signal. 2024 Jan 25;22(1):68. doi: 10.1186/s12964-023-01421-9. Cell Commun Signal. 2024. PMID: 38273295 Free PMC article. Review.
-
Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery.Mar Drugs. 2015 Aug 7;13(8):4967-84. doi: 10.3390/md13084967. Mar Drugs. 2015. PMID: 26262624 Free PMC article. Review.
References
-
- Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ. Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene. 1990;5:1329–1336. This paper and [2-6] were the first studies to report the cloning of Jaks. - PubMed
-
- Wilks AF. Cloning members of protein-tyrosine kinase family using polymerase chain reaction. Methods Enzymol. 1991;200:533–546. See [1] - PubMed
-
- Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene. 1992;7:1347–1353. See [1] - PubMed
-
- Krolewski JJ, Lee R, Eddy R, Shows TB, Dalla-Favera R. Identification and chromosomal mapping of new human tyrosine kinase genes. Oncogene. 1990;5:277–282. See [1] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous